Clinical and Economic Outcomes Associated with Low-Dose Fluticasone Propionate Versus Montelukast in Children with Asthma Aged 4 to 11 Years

@inproceedings{Stanford2012ClinicalAE,
  title={Clinical and Economic Outcomes Associated with Low-Dose Fluticasone Propionate Versus Montelukast in Children with Asthma Aged 4 to 11 Years},
  author={Richard Hiraiwa Stanford and Manan B Shah and Sham L Chaudhari},
  booktitle={The open respiratory medicine journal},
  year={2012}
}
OBJECTIVE Inhaled corticosteroids (ICS) are preferred first-line controller agents for adults and adolescents with asthma. There is limited effectiveness data comparing ICS to leukotriene receptor antagonists (LTRA) in children with asthma aged 4 to 11 years. METHODS A retrospective, matched cohort study was conducted using medical and pharmacy claims… CONTINUE READING